91 related articles for article (PubMed ID: 38635549)
1. Kinase mutations in human disease: interpreting genotype-phenotype relationships.
Lahiry P; Torkamani A; Schork NJ; Hegele RA
Nat Rev Genet; 2010 Jan; 11(1):60-74. PubMed ID: 20019687
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive spectrum of BRCA1 and BRCA2 deleterious mutations in breast cancer in Asian countries.
Kwong A; Shin VY; Ho JC; Kang E; Nakamura S; Teo SH; Lee AS; Sng JH; Ginsburg OM; Kurian AW; Weitzel JN; Siu MT; Law FB; Chan TL; Narod SA; Ford JM; Ma ES; Kim SW
J Med Genet; 2016 Jan; 53(1):15-23. PubMed ID: 26187060
[TBL] [Abstract][Full Text] [Related]
3. Predisposing deleterious variants in the cancer-associated human kinases in the global populations.
Khan SA; Anwar M; Gohar A; Roosan MR; Hoessli DC; Khatoon A; Shakeel M
PLoS One; 2024; 19(4):e0298747. PubMed ID: 38635549
[TBL] [Abstract][Full Text] [Related]
4. Multilayer View of Pathogenic SNVs in Human Interactome through In Silico Edgetic Profiling.
Cui H; Zhao N; Korkin D
J Mol Biol; 2018 Sep; 430(18 Pt A):2974-2992. PubMed ID: 30017919
[TBL] [Abstract][Full Text] [Related]
5. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
6. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
7. Distribution bias analysis of germline and somatic single-nucleotide variations that impact protein functional site and neighboring amino acids.
Pan Y; Yan C; Hu Y; Fan Y; Pan Q; Wan Q; Torcivia-Rodriguez J; Mazumder R
Sci Rep; 2017 Feb; 7():42169. PubMed ID: 28176830
[TBL] [Abstract][Full Text] [Related]
8. Rare genetic mutations in Pakistani patients with dilated cardiomyopathy.
Shakeel M; Irfan M; Khan IA
Gene; 2018 Oct; 673():134-139. PubMed ID: 29886034
[TBL] [Abstract][Full Text] [Related]
9. Germline rare deleterious variant load alters cancer risk, age of onset and tumor characteristics.
Esai Selvan M; Onel K; Gnjatic S; Klein RJ; Gümüş ZH
NPJ Precis Oncol; 2023 Jan; 7(1):13. PubMed ID: 36707626
[TBL] [Abstract][Full Text] [Related]
10. The Pioneer Advantage: Filling the blank spots on the map of genome diversity in Europe.
Oleksyk TK; Wolfsberger WW; Schubelka K; Mangul S; O'Brien SJ
Gigascience; 2022 Sep; 11():. PubMed ID: 36085557
[TBL] [Abstract][Full Text] [Related]
11. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
12. FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?
van Rhijn BWG; Mertens LS; Mayr R; Bostrom PJ; Real FX; Zwarthoff EC; Boormans JL; Abas C; van Leenders GJLH; Götz S; Hippe K; Bertz S; Neuzillet Y; Sanders J; Broeks A; van der Heijden MS; Jewett MAS; Marquez M; Stoehr R; Zlotta AR; Eckstein M; Soorojebally Y; Roshani H; Burger M; Otto W; Radvanyi F; Sirab N; Pouessel D; Wullich B; van der Kwast TH; Malats N; Hartmann A; Allory Y; Zuiverloon TCM
Eur Urol; 2020 Nov; 78(5):682-687. PubMed ID: 32682615
[TBL] [Abstract][Full Text] [Related]
13. FGFR3 signaling and function in triple negative breast cancer.
Chew NJ; Nguyen EV; Su SP; Novy K; Chan HC; Nguyen LK; Luu J; Simpson KJ; Lee RS; Daly RJ
Cell Commun Signal; 2020 Jan; 18(1):13. PubMed ID: 31987043
[TBL] [Abstract][Full Text] [Related]
14. RNA sequencing reveals an additional Crz1-binding motif in promoters of its target genes in the human fungal pathogen Candida albicans.
Xu H; Fang T; Omran RP; Whiteway M; Jiang L
Cell Commun Signal; 2020 Jan; 18(1):1. PubMed ID: 31900175
[TBL] [Abstract][Full Text] [Related]
15. Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic Targets.
Torres-Ayuso P; Brognard J
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817861
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
